Australia Stock Exchange release from NEUROTECH : Further Success with Preclinical Testing Program - MS Models
07/07/2021 24:29
Australia Stock Exchange release from NEUROTECH NTI.AX : Further Success with Preclinical Testing Program - MS Models
Recent news on Neurotech International
See all newsBrief: Neurotech International Says Anthony Filippis Resigns As CEO, MD
Brief: Neurotech International Appoints Mark Davies As Executive Chairman
Brief: Neurotech International Receives Binding Commitments For Around A$4.50 Million In Placement At A$0.014 Per Share
Australia's Neurotech International slips to a month low on discounted placement
Brief: Neurotech International Requests Trading Halt